NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
TVTX Travere Therapeutic
- 17.180
- -0.220-1.26%
Close Dec 20 16:00 ET
- 17.840
- +0.660+3.84%
Post 20:01 ET
1.50BMarket Cap-3.75P/E (TTM)
17.880High17.130Low3.70MVolume17.130Open17.400Pre Close63.91MTurnover5.01%Turnover RatioLossP/E (Static)87.03MShares20.33052wk High-49.09P/B1.27BFloat Cap5.12052wk Low--Dividend TTM73.88MShs Float37.040Historical High--Div YieldTTM4.31%Amplitude0.000Historical Low17.275Avg Price1Lot Size
About Travere Therapeutic Company
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
Company Profile
SymbolTVTX
Company NameTravere Therapeutic
Listing DateJan 10, 2014
Founded2008
CEODr. Eric M. Dube, PhD
MarketNASDAQ
Employees380
Fiscal Year Ends12-31
Address3611 Valley Centre Drive,Suite 300
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-888-969-7879
Websitehttp://www.travere.com
Company Executives
- Name
- Position
- Salary
- Dr. Eric M. Dube, PhD
- Director, President and Chief Executive Officer
- 7.57M
- Sandra Calvin
- Senior Vice President and Chief Accounting Officer
- --
- Peter Heerma
- Chief Commercial Officer
- 2.00M
- Christopher Cline
- Chief Financial Officer
- 1.97M
- Dr. Jula Inrig
- Chief Medical Officer
- --
- Elizabeth E. Reed
- Senior Vice President, General Counsel and Corporate Secretary
- 2.02M
- William E. Rote
- Senior Vice President, Research and Development
- 2.05M
- Gary A. Lyons
- Chairman of the Board
- 392.98K
- Timothy P. Coughlin
- Independent Director
- 385.48K
- John A. Orwin
- Independent Director
- 372.98K
- Dr. Suzanne L. Bruhn, PhD
- Independent Director
- 372.36K
- Dr. Roy D. Baynes, M.D.,PhD
- Independent Director
- 376.73K
- Ron Squarer
- Independent Director
- 367.98K
- Ruth WilliaBrinkley
- Independent Director
- 365.48K
- Jeffrey A. Meckler
- Independent Director
- 379.98K
- Sandra E. Poole
- Independent Director
- 369.86K
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.